Are Dermatology Prior Authorization Delays Slowing Down Reimbursements in 2026?

Image
Yes, dermatology prior authorization delays are increasingly slowing down reimbursements in 2026 as payers expand utilization review policies for high-cost dermatologic treatments and procedures. Many dermatology practices are experiencing longer approval timelines, stricter documentation requirements, and higher administrative workloads before services can even be billed. Prior authorizations are designed to ensure medical necessity, but in dermatology—where biologics, specialty medications, and advanced treatments are common—the process has become more complex. As a result, delays at the authorization stage are now one of the leading contributors to reimbursement slowdowns. Why Prior Authorizations Are Increasing in Dermatology Several industry changes are contributing to the rise in dermatology prior authorization delays . Payers are expanding review requirements for treatments that involve: Biologic therapies for psoriasis and eczema Advanced dermatologic procedures High-...

4 Common Misconceptions about Ambulatory Surgical Centers (ASC)

 

4commonmisconceptionsaboutambulatorysurgicalcentersasc.jpg

Ambulatory Surgical Centers or ASCs as it is commonly called were first established in Phoenix, Arizona in 1970 by two physicians who wanted to provide comfortable care to the people in their community so that they could avoid more impersonal venues like hospitals. Slowly over the years with Medicare approving payments to ASCs they have gained prominence and in some cases are scoring over the normal hospitals for certain procedures.

The fact that ASCs provide a high-quality yet cost-effective alternative to the inpatient care provided at hospitals has seen a surge in outpatient centers. Hospitals grappling with scheduling delays, slow operating room turnover, and budget cuts which have impacted the purchase of new medical equipment, coupled with other operational issues that have prompted patients to visit ASCs to receive care.

Industry Snippet

The revenue of the ASC is slated at $28 billion with an expected growth rate of over 5 percent between the years 2010– 015. ASCs are said to have a low level of market share concentration. A case in point being the four largest market players will generate less than 12 percent of the total revenue. However, over the next few years, it is expected that the industry will consolidate with many large ASCs taking over the smaller ones and forging associations with other healthcare providers.

Demystifying 4 Common Misconceptions about Ambulatory Surgical Centers

Ambulatory Surgical Centers and hospitals are not different entities

People should realize that ASCs and hospitals are two different entities. It is not necessary that the kind of facilities that hospitals have ASCs might have them too. Of course, patient care should not be compromised but it would be incorrect to expect the same treatment at an ASC as a hospital.

ASCs can help in getting surgery done cheaply

This is one of the sad misconceptions where people feel that if one needs to get a procedure done cheaply they can avoid a hospital and go to an ASC. However, one needs to remember that ASCs get the same Medicare certification and other accreditations that a hospital needs to get and the motive for ASC is to provide high-quality care at a lower cost compared to a hospital but it is by no means cheap as they have standards to uphold.

ASCs suit everyone

To learn more about The 4 Common Misconceptions about Ambulatory Surgical Centers (ASC), click here: https://bit.ly/3qJ0zBM  Contact us at info@medicalbillersandcoders.com888-357-3226.

Comments

Popular posts from this blog

How to Reduce Days in A/R with Smart Denial Management Strategies

How Outsourced Medical Billing Can Improve Your Practice’s Profitability

Is Your Neurology Billing Outsourcing Helping or Hurting You at Year-End?